FDA Recall: Altaire Pharmaceuticals Issues New Voluntary Recall of <br>Over-The-Counter Ophthalmic Products Sold by Natural Ophthalmics and TRP Company

Altaire Pharmaceuticals has issued a new voluntary recall for several different medications, including prescription and over-the-counter (OTC) drug products due to management concerns regarding the sufficiency of quality assurance controls over critical systems in the manufacturing facility. This recall is being carried out to the retail level and is only for the specific products and lots listed here. To date, Altaire has not received any reports of adverse events for these products.

Altaire has notified Natural Ophthalmics and TRP Company by e-mail with specific directions for return of the impacted lots.

Questions regarding this recall may be directed to Altaire by calling 800-258-2471 or emailing otcdruggist@aol.com, Monday through Friday, from 8:30 a.m. to 5:00 p.m. ET.

The FDA asks healthcare professionals and patients to report unexpected side effects or quality problems associated with Altaire to FDA’s MedWatch Adverse Event Reporting program:

If you have additional questions, please contact Jillian Winans, regulatory affairs specialist, at jwinans@ascrs.org or 703-591-2220.